Article Text
Statistics from Altmetric.com
- Bioprosthesis
- transcutaneous aortic valve implantation
- TAVI
- valve in valve
- aortic valve disease
- prosthetic heart valves
An 85-year-old man presented acutely with NYHA class IV symptoms requiring continuous intravenous infusion of diuretics over several weeks. Echocardiography showed preserved left ventricular function and a severe central jet of regurgitation through a stented bioprosthetic aortic valve (25 mm Carpentier Edwards, implanted in 1994, Edwards Lifesciences Ltd, Irvine, California, USA) (figure 1A,B, videos 1 and 2). High Euroscore and multiple comorbidities (including chronic cardiac and renal failure) precluded reoperation. Transfemoral transcatheter aortic valve implantation (TAVI) using a self-expanding CoreValve was successfully …
Footnotes
Competing interests None.
Patient consent Obtained.
Provenance and peer review Not commissioned; not externally peer reviewed.